Jay Duffner
Johnson & Johnson (United States)(US)Johnson & Johnson (Israel)(IL)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Proteoglycans and glycosaminoglycans research
Most-Cited Works
- → M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis(2011)176 cited
- → Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events(2016)157 cited
- → M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study(2018)142 cited
- → Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease(2019)45 cited
- → Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for Structure–Activity Relationship Studies(2014)39 cited
- → Bioactivity screening of partially desulfated low-molecular-weight heparins: A structure/activity relationship study(2011)34 cited
- → Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor(2019)31 cited
- → Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties(2025)20 cited
- → Characterization of heparin–protein interaction by saturation transfer difference (STD) NMR(2014)19 cited
- → Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation*(2018)18 cited